Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases.
Khanna
Dinesh
D
David Geffen School of Medicine at UCLA, 1000 Veteran Avenue, Room 32-59 Rehabilitation Building, Los Angeles, CA 90095, USA. dkhanna@mednet.ucla.edu
Agrawal
Harsh
H
Clements
Philip J
PJ
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000188:drug therapy* / Q000503:physiopathology; D005208:Fasciitis / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use*; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D013256:Steroids; D000069285:Infliximab; D011241:Prednisone